NAP1L1P2

Across TCGA pan-cancer cohorts, NAP1L1P2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of NAP1L1P2’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where NAP1L1P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NAP1L1P2 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

HNSC, CHOL, and ESCA are the cancer types where NAP1L1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NAP1L1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.030	.008	4	view →
CHOL	All	II,III,IV	+0.435	.013	2	view →
ESCA	All	II,III,IV	+0.290	.041	2	view →
KICH	Male	All	−0.108	.014	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

NAP1L1P2–HNSC

Open the HNSC breakdown →